Yahoo Web Search

Mail

  1. Sort by

  1. ViroCyt(R) Continues to Innovate for the Gene Therapy Field

    Marketwired via Yahoo! FinanceMay 04 05:30 AM

    ViroCyt®, the leader in rapid virus quantification, announced today the release of new member of the ViroTag® portfolio of antibody-based detection reagents: ViroTag AAV5.Adeno-Associated Virus, or AAV, ...

  2. Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In Multiple Presentations ...

    PR Newswire via Yahoo! FinanceMay 09 04:00 AM

    RICHMOND, Calif., May 9, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (SGMO), the leader in therapeutic genome editing, presented new preclinical data from the Company's proprietary In Vivo Protein Replacement Platform™ (IVPRP) program in Mucopolysaccharidosis I (MPS I) providing histologic evidence of tissue clearance of toxic glycosaminoglycans (GAGs) after a single systemic treatment ...

  3. ViroCyt(R) Continues to Innovate for the Gene Therapy Field

    MarketwireMay 04 07:25 AM

    BROOMFIELD, CO --(Marketwired - May 04, 2016) - ViroCyt®, the leader in rapid virus quantification, announced today the release of new member of the ViroTag® portfolio of antibody-based detection reagents: ViroTag AAV5.

  1. 4 results